Funding Received
$34.8 Million in 1 Round from 3 Investors
Most Recent Funding
$34.8 Million Series B on November 11, 2010
Headquarters:
Atlanta, GA
Description:
Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions.
Categories:
Biotechnology
Website:
http://www.arborpharma.com

Company Details

Update

Arbor Pharmaceuticals, Inc. operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company’s products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, Inc. was founded in 2006 and is based in Raleigh, North Carolina.

Current Team (10)

Update

Past Team (1)

Update

Funding Rounds (1) - $34.8M

Update

Offices/Locations (1)

Update
  • HQ

    980 Hammond Drive

    Building Two, Suite 1250

    Atlanta, GA 30328

    USA